CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $16,359,000 | -5.2% | 699,415 | +16.8% | 0.68% | -8.6% |
| Q4 2020 | $17,250,000 | +47.3% | 598,951 | +3.6% | 0.74% | +27.4% |
| Q3 2020 | $11,713,000 | -10.8% | 578,134 | +32.3% | 0.58% | -31.5% |
| Q2 2020 | $13,136,000 | +148.2% | 437,131 | +159.6% | 0.85% | +140.2% |
| Q1 2020 | $5,292,000 | – | 168,381 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |